K-Ras and mitochondria: Dangerous liaisons
暂无分享,去创建一个
[1] M. Barbacid,et al. Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient. , 1984, Science.
[2] W. Wheaton,et al. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity , 2010, Proceedings of the National Academy of Sciences.
[3] M. Roizen,et al. Hallmarks of Cancer: The Next Generation , 2012 .
[4] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[5] D. Levy,et al. Mitochondrial STAT3 Supports Ras-Dependent Oncogenic Transformation , 2009, Science.
[6] A. Balmain,et al. Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogene , 1983, Nature.
[7] G. Garcia-Manero,et al. K-rasG12V transformation leads to mitochondrial dysfunction and a metabolic switch from oxidative phosphorylation to glycolysis , 2011, Cell Research.
[8] C. Marshall,et al. Identification of transforming gene in two human sarcoma cell lines as a new member of the ras gene family located on chromosome 1 , 1983, Nature.
[9] K. Kinzler,et al. Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells , 2009, Science.
[10] A. Jemal,et al. Global Cancer Statistics , 2011 .
[11] Emma Saavedra,et al. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy. , 2010, Molecular aspects of medicine.
[12] O. Rath,et al. MAP kinase signalling pathways in cancer , 2007, Oncogene.
[13] F. Domann,et al. α-Tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex II , 2008, Oncogene.
[14] B. Zhivotovsky,et al. Mitochondria in cancer cells: what is so special about them? , 2008, Trends in cell biology.
[15] J. Neuzil,et al. Anticancer drugs targeting the mitochondrial electron transport chain. , 2011, Antioxidants & redox signaling.